⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Safety Testing of Adding Nivolumab to Chemotherapy in Patients With Intermediate and High-Risk Local-Regionally Advanced Head and Neck Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Safety Testing of Adding Nivolumab to Chemotherapy in Patients With Intermediate and High-Risk Local-Regionally Advanced Head and Neck Cancer

Official Title: Safety Evaluations of Nivolumab (Anti-PD-1) Added To Chemotherapy (CRT) Platforms In Patients With Intermediate And High-Risk Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma

Study ID: NCT02764593

Study Description

Brief Summary: This study will evaluate the safety of adding nivolumab to several chemotherapy platforms with weekly cisplatin, high-dose cisplatin, cetuximab or radiation therapy alone.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Stanford Cancer Institute, Palo Alto, California, United States

University of Florida Cancer Center at Orlando Health, Orlando, Florida, United States

Emory University/Winship Cancer Institute, Atlanta, Georgia, United States

University of Louisville, Louisville, Kentucky, United States

University Hospitals Cleveland Medical Center, Cleveland, Ohio, United States

Ohio State University, Columbus, Ohio, United States

Providence Portland Medical Center, Portland, Oregon, United States

UPMC - Shadyside Hospital, Pittsburgh, Pennsylvania, United States

MD Anderson Cancer Center, Houston, Texas, United States

Inova Fairfax Hospital, Falls Church, Virginia, United States

University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States

Contact Details

Name: Maura Gillison, MD, PhD

Affiliation: RTOG Foundation

Role: PRINCIPAL_INVESTIGATOR

Name: Robert Ferris, MD, PhD

Affiliation: RTOG Foundation

Role: PRINCIPAL_INVESTIGATOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: